更年期血管运动症状的药物治疗的进步
Stephanie Young Moss1, Angie Lee2, James A Simon3
1Menopause in Color, Indianapolis, IN, USA.
Drugs
|October 1, 2025
概括
更年期期间的血管运动症状 (VMS) 显著影响生活质量. 针对神经素受体的新型非激素疗法为无法使用更年期激素治疗的女性提供了有效的治疗选择.
科学领域:
- 生殖医学和内分泌学.
- 妇女健康 妇女健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 血管运动症状 (VMS) 是更年期的一个标志,影响高达80%的女性,并对生活质量,健康和职业活动产生负面影响.
- 静脉硬化与不良健康结果有关,包括冠状动脉心脏病和认知障碍风险增加.
- 更年期激素治疗 (MHT) 是有效的,但对一些女性来说是禁忌或不理想的.
研究的目的:
- 审查了解VMS病理生理学的最新进展.
- 讨论目前的,新的和正在研究的VMS治疗方案.
- 为了突出MHT之外不断扩大的治疗景观.
主要方法:
- 关于VMS病理生理学的最新进展的文献综述.
- 对已批准的非激素疗法的分析,包括针对神经素 (NK) 的药物.
- 目前正在第二阶段试验中的研究药物的概述.
主要成果:
- 费索利内坦和埃利桑尼坦,NK3和NK1/NK3受体对抗剂,已被批准为VMS的非激素治疗.
- 一些研究药物 (Q-122,PhytoSERM,NOE-115,GS1-144,HS-10384) 正处于第二阶段试验中.
- 这些新的选择为那些不能或选择不使用MHT的女性提供了替代方案.
结论:
- 对VMS病理生理学的理解正在不断发展.
- 新的非激素疗法,特别是NK受体对抗剂,在VMS管理方面取得了重大进展.
- 试验药物的管道表明在治疗更年期VMS.中继续进行创新.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
1.0K
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
16.1K
相关概念视频
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Hormonal Regulation of the Menstrual Cycle
1.5K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.5K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K
